1. Home
  2. List
Reference Patent

Reference - List

  • 8 Hits
  • Search Condition : Filter (MeSH = Ovarian Neoplasms / mortality)
Species Resource Title
Human and Animal Cells JHOC-5(RCB1520) , JHOC-7(RCB1688) , JHOC-8(RCB1723) , JHOC-9(RCB2226) Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.
Human and Animal Cells JHOC-7(RCB1688) , JHOC-9(RCB2226) MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
DNA material , Human and Animal Cells pCAmGCSF (RDB01522) , pCAZ 2 (RDB01870) , OV2944-HM-1(RCB1483) The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.
Human and Animal Cells OV2944-HM-1(RCB1483) , JHOS-2(RCB1521) Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.
Human and Animal Cells Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation.
Human and Animal Cells JHOC-9(RCB2226) , JHOC-5(RCB1520) Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.
Human and Animal Cells JHOC-9(RCB2226) , JHOC-5(RCB1520) Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.
Human and Animal Cells JHOC-9(RCB2226) Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma.